These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33079828)

  • 1. Targeting the Vascular Endothelium in the Treatment of COVID-19.
    Suvorava T; Kaesemeyer W
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):1-3. PubMed ID: 33079828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury.
    Nicosia RF; Ligresti G; Caporarello N; Akilesh S; Ribatti D
    Am J Pathol; 2021 Aug; 191(8):1374-1384. PubMed ID: 34033751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
    Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.
    Lee C; Choi WJ
    Arch Pharm Res; 2021 Jan; 44(1):99-116. PubMed ID: 33398692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism.
    Rochette L; Zeller M; Cottin Y; Vergely C
    Trends Endocrinol Metab; 2021 Nov; 32(11):875-889. PubMed ID: 34593305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors.
    Kandasamy M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):561-567. PubMed ID: 33394134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19.
    Ali A; Kamjani MH; Kesselman MM
    Recent Pat Antiinfect Drug Discov; 2020; 15(2):104-112. PubMed ID: 32962623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2.
    Lei Y; Zhang J; Schiavon CR; He M; Chen L; Shen H; Zhang Y; Yin Q; Cho Y; Andrade L; Shadel GS; Hepokoski M; Lei T; Wang H; Zhang J; Yuan JX; Malhotra A; Manor U; Wang S; Yuan ZY; Shyy JY
    Circ Res; 2021 Apr; 128(9):1323-1326. PubMed ID: 33784827
    [No Abstract]   [Full Text] [Related]  

  • 10. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
    Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
    Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
    Rossouw TM; Anderson R; Manga P; Feldman C
    Front Immunol; 2022; 13():776861. PubMed ID: 35185878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.
    Iqubal A; Hoda F; Najmi AK; Haque SE
    Drug Res (Stuttg); 2021 Apr; 71(4):173-179. PubMed ID: 33434935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome.
    Du P; Geng J; Wang F; Chen X; Huang Z; Wang Y
    Int J Med Sci; 2021; 18(6):1356-1362. PubMed ID: 33628091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?
    Wilczynski SA; Wenceslau CF; McCarthy CG; Webb RC
    Am J Hypertens; 2021 Apr; 34(4):304-306. PubMed ID: 33877321
    [No Abstract]   [Full Text] [Related]  

  • 16. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.
    Gupta A; Chun HJ
    Front Immunol; 2021; 12():693085. PubMed ID: 34248990
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.
    Rodríguez C; Luque N; Blanco I; Sebastian L; Barberà JA; Peinado VI; Tura-Ceide O
    Am J Respir Cell Mol Biol; 2021 Apr; 64(4):407-415. PubMed ID: 33180562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
    Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D
    Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytokine storm and thyroid hormone changes in COVID-19.
    Croce L; Gangemi D; Ancona G; Liboà F; Bendotti G; Minelli L; Chiovato L
    J Endocrinol Invest; 2021 May; 44(5):891-904. PubMed ID: 33559848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.